IBM (NYSE: IBM) is working with the Union for International Cancer Control (UICC) to create the world's largest and most comprehensive clinical dataset on cancer patients by building cancer registries in developing nations. The effort will begin in Sub-Saharan Africa, where less than 1% of the region's population is covered by a cancer registry.